[Federal Register Volume 61, Number 30 (Tuesday, February 13, 1996)]
[Notices]
[Page 5570]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-3169]



-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE
Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 20, 1995, Ansys, 
Inc., 2 Goodyear, Irvine, California 92718, made application to the 
Drug Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Cathinone (1235)...........................  I                          
Methcathinone (1237).......................  I                          
Heroin (9200)..............................  I                          
Phencyclidine (7471).......................  II                         
1-Piperidinocyclohexanecarbo -nitrile        II                         
 (8603).                                                                
Levorphanol (9220).........................  II                         
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
produce standards and controls for in-vitro diagnostic drug testing 
systems.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quituplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than April 15, 1996.

    Dated: February 2, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-3169 Filed 2-12-96; 8:45 am]
BILLING CODE 4410-09-M